Currently out of the existing stock ratings of Brandon Henry, 25 are a BUY (48.08%), 27 are a HOLD (51.92%).

Brandon Henry

Work Performance Price Targets & Ratings Chart

Analyst Brandon Henry, carries an average stock price target met ratio of 91.99% that have a potential upside of 19.02% achieved within 302 days. Previously, Brandon Henry worked at RBC.

Brandon Henry’s has documented 110 price targets and ratings displayed on 13 stocks. The coverage was on Healthcare, Communication Services sectors.

Most recent stock forecast was given on PEN, Penumbra at 18-Jul-2022.

Wall Street Analyst Brandon Henry

Analyst best performing recommendations are on TRXC (ASENSUS SURGICAL).
The best stock recommendation documented was for TRXC (ASENSUS SURGICAL) at 8/8/2019. The price target of $13 was fulfilled within 1 day with a profit of $1.3 (11.11%) receiving and performance score of 111.11.

Average potential price target upside

ISRG Intuitive Surgical NUVA NuVasive SYK Stryker VAR Varian Medical Systems ZBH Zimmer Biomet Holdings BAX Baxter International MDT Medtronic PLC EW Edwards Lifesciences Corp JNJ Johnson & Johnson PEN Penumbra WMGI Wright Medical Group N.V WMG Warner Music Group TRXC Asensus Surgical

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 26-Jan-2026

$485

$56.88 (13.29%)

$485

Buy Since 16-Oct-2023

$503

$74.88 (17.49%)

$454

Buy Since 18-Jul-2023

$550

$121.88 (28.47%)

$500

Buy Since 24-May-2017

$486

$57.88 (13.52%)

$487

Buy Since 11-Oct-2024

$475

$46.88 (10.95%)

$450

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?